maraviroc 150 MG Oral Tablet
- RxCUI
- 728223
- RxNorm name
- maraviroc 150 MG Oral Tablet
- Display name
- maraviroc 150 MG Oral Tablet
- Full name
- maraviroc 150 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Maraviroc | MARAVIROC | A-S Medication Solutions | 5c4a1da5-a8e1-4038-970d-fb15c189c35e | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | Navinta LLC | 211290a4-5e26-4784-aa99-8ccaf2eaaa15 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | Zydus Pharmaceuticals USA Inc. | 9bba17ba-0bc5-430c-96d1-c568e236a0ed | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | A2A Integrated Pharmaceuticals | 2a16417d-a3b8-483b-9dfe-d5263cc16538 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | Hetero Labs Limited | 9db91945-127e-4bb6-970a-ff1e36dde658 | 2024-07-04 | Boxed warning, Warnings, Adverse reactions | 728223 |
| SELZENTRY | MARAVIROC | A-S Medication Solutions | 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | i3 Pharmaceuticals, LLC | f7b9c67b-10c6-45b5-b2a8-952cd350b0b1 | 2023-08-18 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | XLCare Pharmaceuticals Inc. | d3a728e2-1866-462e-bfcc-5f3c9dd88794 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 728223 |
| SELZENTRY | MARAVIROC | ViiV Healthcare Company | 46f30ac5-c96b-429e-976d-8c5ee1c0761b | 2022-09-26 | Boxed warning, Warnings, Adverse reactions | 728223 |
| Maraviroc | MARAVIROC | Camber Pharmaceuticals, Inc. | 09ec3e79-c0d3-4b8f-80d8-0a854c4ca339 | 2022-01-27 | Boxed warning, Warnings, Adverse reactions | 728223 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 46f30ac5-c96b-429e-976d-8c5ee1c0761b | maraviroc 150 MG Oral Tablet | PSN | 25 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20220926 |
| 46f30ac5-c96b-429e-976d-8c5ee1c0761b | maraviroc 150 MG Oral Tablet | SCD | 25 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20220926 |
| 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | maraviroc 150 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20231110 |
| 3c52dddd-0457-41cd-99e0-d30d4fd00ec5 | maraviroc 150 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007 | 20231110 |
| f7b9c67b-10c6-45b5-b2a8-952cd350b0b1 | maraviroc 150 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20230818 |
| f7b9c67b-10c6-45b5-b2a8-952cd350b0b1 | maraviroc 150 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20230818 |
| 2a16417d-a3b8-483b-9dfe-d5263cc16538 | maraviroc 150 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250228 |
| 2a16417d-a3b8-483b-9dfe-d5263cc16538 | maraviroc 150 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250228 |
| 09ec3e79-c0d3-4b8f-80d8-0a854c4ca339 | maraviroc 150 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20220127 |
| 09ec3e79-c0d3-4b8f-80d8-0a854c4ca339 | maraviroc 150 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20220127 |
| 211290a4-5e26-4784-aa99-8ccaf2eaaa15 | maraviroc 150 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250623 |
| 211290a4-5e26-4784-aa99-8ccaf2eaaa15 | maraviroc 150 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250623 |
| 9bba17ba-0bc5-430c-96d1-c568e236a0ed | maraviroc 150 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250515 |
| 9bba17ba-0bc5-430c-96d1-c568e236a0ed | maraviroc 150 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20250515 |
| 9db91945-127e-4bb6-970a-ff1e36dde658 | maraviroc 150 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20240704 |
| 9db91945-127e-4bb6-970a-ff1e36dde658 | maraviroc 150 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20240704 |
| d3a728e2-1866-462e-bfcc-5f3c9dd88794 | maraviroc 150 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20230712 |
| d3a728e2-1866-462e-bfcc-5f3c9dd88794 | maraviroc 150 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007 | 20230712 |